Edition:
India

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

2.17USD
15 Dec 2017
Change (% chg)

$0.09 (+4.33%)
Prev Close
$2.08
Open
$2.06
Day's High
$2.19
Day's Low
$2.06
Volume
1,860
Avg. Vol
4,734
52-wk High
$5.90
52-wk Low
$1.75

Select another date:

Wed, Nov 15 2017

BRIEF-Xenetic Biosciences qtrly ‍loss per share $0.26​

* Xenetic Biosciences Inc- ‍current cash position is about $8.0 million, sufficient to fund operations through Q2 of 2018​‍​ Source text for Eikon: [ID: nBw9dWFZHa] Further company coverage:

BRIEF-Xenetic Biosciences enters into sublicense agreement with subsidiary of Shire Plc

* Xenetic Biosciences enters into sublicense agreement related to its Polyxen technology with Baxalta Inc., a wholly-owned subsidiary of Shire Plc

BRIEF-XENETIC BIOSCIENCES PROVIDES UPDATE ON ANNUAL MEETING OF STOCKHOLDERS

* XENETIC BIOSCIENCES PROVIDES UPDATE ON ANNUAL MEETING OF STOCKHOLDERS

BRIEF-Xenetic Biosciences reports Q2 loss per share $0.34

* Xenetic biosciences reports 2017 second quarter financial results and provides business update

BRIEF-Xenetic Biosciences commences patient enrollment in phase 2 study evaluating XBIO-101 in conjunction with Progestin therapy for the treatment of endometrial cancer

* Xenetic Biosciences commences patient enrollment in phase 2 study evaluating XBIO-101 in conjunction with Progestin therapy for the treatment of endometrial cancer

Select another date: